GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » EV-to-EBITDA

Immatics NV (Immatics NV) EV-to-EBITDA : -7.02 (As of May. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Immatics NV EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Immatics NV's enterprise value is $672.82 Mil. Immatics NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-95.90 Mil. Therefore, Immatics NV's EV-to-EBITDA for today is -7.02.

The historical rank and industry rank for Immatics NV's EV-to-EBITDA or its related term are showing as below:

IMTX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -16.96   Med: -2.39   Max: 17.34
Current: -7.08

During the past 6 years, the highest EV-to-EBITDA of Immatics NV was 17.34. The lowest was -16.96. And the median was -2.39.

IMTX's EV-to-EBITDA is ranked worse than
100% of 465 companies
in the Biotechnology industry
Industry Median: 9.34 vs IMTX: -7.08

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Immatics NV's stock price is $11.02. Immatics NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.294. Therefore, Immatics NV's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Immatics NV EV-to-EBITDA Historical Data

The historical data trend for Immatics NV's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immatics NV EV-to-EBITDA Chart

Immatics NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - -1.60 -7.01 5.65 -4.58

Immatics NV Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.65 -3.35 -8.08 -7.74 -4.58

Competitive Comparison of Immatics NV's EV-to-EBITDA

For the Biotechnology subindustry, Immatics NV's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immatics NV's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immatics NV's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Immatics NV's EV-to-EBITDA falls into.



Immatics NV EV-to-EBITDA Calculation

Immatics NV's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=672.817/-95.898
=-7.02

Immatics NV's current Enterprise Value is $672.82 Mil.
Immatics NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-95.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immatics NV  (NAS:IMTX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Immatics NV's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=11.02/-1.294
=At Loss

Immatics NV's share price for today is $11.02.
Immatics NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.294.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Immatics NV EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Immatics NV's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Immatics NV (Immatics NV) Business Description

Traded in Other Exchanges
Address
Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Immatics NV (Immatics NV) Headlines

From GuruFocus